Viking Therapeutics VKTX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's short-term investments?
- Viking Therapeutics (VKTX) reported short-term investments of $484.85M in Q1 2026.
- How has Viking Therapeutics's short-term investments changed year-over-year?
- Viking Therapeutics's short-term investments decreased by 40.4% year-over-year, from $813.92M to $484.85M.
- What is the long-term trend for Viking Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Viking Therapeutics's short-term investments has grown at a 19.7% compound annual growth rate (CAGR), from $219.27M to $539.93M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.